U.S. Markets close in 4 hrs 42 mins

In the Saga of Rite Aid Corporation, Amazon Plays Godot

Dana Blankenhorn

Spoiler alert. In the Samuel Beckett play Waiting for Godot, Godot never shows up. In the continuing saga of Rite Aid Corp. (NYSE:RAD), Amazon.Com Inc. (NASDAQ:AMZN) is now playing the part of Godot.

In the Saga of Rite Aid Corporation, Amazon Plays Godot

Source: Mike Mozart via Flickr

Amazon is the off-stage character dominating the on-stage discussion. Its ambition to enter the pharmacy business is well-known. But will it?

Rite Aid, with 2,336 stores following the sale of its other operations to Walgreens Boots Alliance Inc. (NYSE:WBA), which would have acquired the whole company but for the Federal Trade Commission’s objections, would seem to be a natural vehicle for such an entrance.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

The remaining Rite Aid stores have average annual sales of $6.1 million and just $3 billion in debt. Combined with a take-out premium, the total cost to Amazon would be considerably less than the $13.7 billion it spent getting into the low-margin grocery business.

So then, why hasn’t there been any action on the stage?

Why the Wait

As with Whole Foods, an Amazon purchase of Rite Aid would give it all the infrastructure needed to get into the pharmacy business, along with physical locations that could be integrated into its network. With Rite Aid, it would acquire all the licenses necessary to not only do retail pharmacy business, but become a pharmacy benefit manager, able to negotiate prices and create standard formularies.

As a standalone business, our Luke Lango writes, Rite Aid remains viable. It is currently valued at just 7.7 times trailing earnings before interest, taxes and depreciation (EBITDA), the metric most used to evaluate potential acquisitions.

But since Lango published this analysis, the stock’s price has fallen from about $2.40 per share to $1.87 per share. The company’s market cap has fallen below $2 billion.

Rite Aid isn’t alone in this. All drug store stocks are falling in the wake of the Amazon rumors. CVS Health Corp. (NYSE:CVS) is down 12% since the Lango story came out. Walgreens is down 17%, a huge hit to its market cap, which now stands at $72 billion.

Like Godot, Amazon looms larger in the imagination than it does on the stage. A startup called NowRX is already taking pharmacy orders in part of California through the Amazon Alexa app.

A recent survey from Wells Fargo & Co. (NYSE:WFC) showed half of all consumers would consider an Amazon pharmacy if it became available. The question then becomes not whether Amazon will enter the business, but whether it needs Rite Aid to do it.

Can Rite Aid Survive?

Absent an Amazon acquisition, what are Rite Aid’s prospects?

Not great. Neither Rite Aid nor its pharmacy benefit manager, EnvisionRX, has the size necessary to get big discounts from drug companies — discounts that are the key to both profits and competitive pricing.

Rite Aid spent $2 billion to acquire Envision in 2015 and the whole company is now worth less than that. Envision has been struggling under Rite Aid’s ownership, with few synergies visible and Envision’s sales declining over the last few quarters.



Still, there remain other boosters of the stock besides Lango. They argue that, with a reduced debt load and a regional rather than national footprint, private equity should be interested in buying the company.  Then again, Amazon could merely be waiting for the dust to settle on the WBA deal before pouncing, which would also allow the price to settle and its own costs to go down.

Bottom Line on RAD Stock

While Rite Aid might make a perfect snack for Amazon, there is no need for Amazon to rush to the pantry. It can let fear take the price of Rite Aid down and buy on its own schedule.

Thus, despite the temptation, this version of Godot is not one I’m buying a ticket for.

Dana Blankenhorn is a financial and technology journalist. He is the author of the historical mystery romance The Reluctant Detective Travels in Time, available now at the Amazon Kindle store. Write him at danablankenhorn@gmail.com or follow him on Twitter at @danablankenhorn. As of this writing he owned shares in AMZN.

More From InvestorPlace

The post In the Saga of Rite Aid Corporation, Amazon Plays Godot appeared first on InvestorPlace.

  • Ford CEO seeks to rally dealers as shares sink to new low
    Business
    Reuters

    Ford CEO seeks to rally dealers as shares sink to new low

    With Ford Motor Co's stock at nearly a nine-year low and the company squeezed by tariffs and trade tensions, Chief Executive Jim Hackett sought to restore confidence among dealers gathered in Las Vegas this week, days ahead of announcing the automaker's third-quarter results. In closed-door meetings with members of Ford's national dealer network, Hackett and other top Ford executives showed off future versions of the popular Explorer and Escape SUVs, as well as new the Ranger mid-sized pickup truck and an unnamed smaller off-road utility vehicle, attendees said. Ford has said it will refresh 75 percent of its North American lineup over the next two years.

  • BMY vs. LLY: Which Stock Should Value Investors Buy Now?
    Business
    Zacks

    BMY vs. LLY: Which Stock Should Value Investors Buy Now?

    Investors interested in Large Cap Pharmaceuticals stocks are likely familiar with Bristol-Myers Squibb (BMY) and Eli Lilly (LLY). The Zacks Rank is a proven strategy that targets companies with positive earnings estimate revision trends, while our Style Scores work to grade companies based on specific traits. Right now, both Bristol-Myers Squibb and Eli Lilly are sporting a Zacks Rank of # 2 (Buy).

  • Here’s why you shouldn’t retire super early — even if you can
    Business
    MarketWatch

    Here’s why you shouldn’t retire super early — even if you can

    Despite the many perks of early retirement — waking up whenever you want, for example — it wasn’t the easiest decision. Earnings tend to peak around 48 for men and about 39 for women, according to an analysis by PayScale.

  • Why Yandex N.V. Stock Plunged Today
    Business
    Motley Fool

    Why Yandex N.V. Stock Plunged Today

    What happened Shares of Yandex N.V. (NASDAQ: YNDX) dropped 17.8% on Thursday following reports that Russia's state-owned Sberbank may take a controlling stake in the country's leading internet search company. More specifically, according to sources speaking

  • What happens if you win Mega Millions' $970M jackpot?
    News
    Associated Press

    What happens if you win Mega Millions' $970M jackpot?

    Despite the terrible odds — one in 302.5 million for those keeping score at home — someone will eventually match all six numbers and win the Mega Millions jackpot, which now stands at $970 million. Here are some answers for someone holding that prized lottery ticket for what would be the second-largest lottery jackpot in U.S. history. Lottery officials recommend winners take a deep breath, put their winning ticket in a safe spot and consult with a reputable financial planner before popping over to the lottery headquarters.

  • Is CenturyLink, Inc. a Buy?
    Business
    Motley Fool

    Is CenturyLink, Inc. a Buy?

    Legacy landline telecom CenturyLink, Inc. (NYSE: CTL) gets plenty of grief. And understandably so, considering that its legacy business, copper wire landline and internet connections is a steadily declining business while fiber and wireless technologies

  • The only positive in autos is Tesla, says Jim Cramer
    F
    CNBC Videos

    The only positive in autos is Tesla, says Jim Cramer

    CNBC's 'Squawk on the Street' discusses Tesla after Tesla CEO Elon Musk announced the low-cost Model 3 vehicle.

  • Finance
    Associated Press

    Schlumberger: 3Q Earnings Snapshot

    THE HAGUE, Netherlands (AP) -- Schlumberger NV (SLB) on Friday reported third-quarter net income of $644 million. The The Hague, Netherlands-based company said it had profit of 46 cents per share.

  • Kinder Morgan Inc.’s CEO Outlines a 4-Step Plan for a Brighter Tomorrow
    Business
    Motley Fool

    Kinder Morgan Inc.’s CEO Outlines a 4-Step Plan for a Brighter Tomorrow

    Kinder Morgan (NYSE: KMI) recently completed a "momentous" quarter according to CEO Steve Kean. Not only did the pipeline giant's financial results beat its expectations, but it was a pivotal quarter on a strategic front, because the company closed the sale of the Trans Mountain Pipeline and locked up another new growth project. Complete the distribution of the Trans Mountain proceeds and continue our discussions on turning the positive indications that we now have from all three rating agencies into positive ratings actions.

  • Love Dividends? 3 Stocks You Might Want to Buy
    Business
    Motley Fool

    Love Dividends? 3 Stocks You Might Want to Buy

    It's even better when you know that the dividend is a big one! You'll get more of those good feelings if you add high-yielding Magellan Midstream Partners, L.P. (NYSE: MMP), General Mills, Inc. (NYSE: GIS), and Tanger Factory Outlet Centers, Inc. (NYSE: SKT) to your income portfolio. It has also been reworking older brands, notably with new yogurt and ice cream products.

  • Home Depot adding hundreds of high-paying jobs in Cobb County
    Finance
    American City Business Journals

    Home Depot adding hundreds of high-paying jobs in Cobb County

    Home Depot is working on an expansion in Cobb County that could add hundreds of high-paying IT and logistics jobs. The Home Depot Inc. (NYSE: HD) would move into at least 200,000 square feet of office space in Pennant Park, a large office development

  • Palo Alto Networks Stock Upgraded: What You Need to Know
    Business
    Motley Fool

    Palo Alto Networks Stock Upgraded: What You Need to Know

    Cybersecurity company Palo Alto Networks (NYSE: PANW) won a big upgrade today when analysts at R.W. Baird announced they're assuming coverage of the stock and raising their price target to $250 a share. If they're right about that, Palo Alto Networks is worth more than 23% more than it currently costs. Many companies offer cybersecurity services, but which one is the best to invest in?

  • Turkish Official Says Jamal Khashoggi's Remains May Have Been Taken Outside Istanbul
    World
    Time

    Turkish Official Says Jamal Khashoggi's Remains May Have Been Taken Outside Istanbul

    The official told The Associated Press that police have established that two vehicles belonging to the consulate, left the building on Oct. 2 — the day Khashoggi had walked into the consulate and vanished. One of the vehicles traveled to the nearby Belgrade Forest while the other traveled to the city of Yalova, across the Sea of Marmara from Istanbul, the official said, speaking on condition of anonymity due to the secrecy of the ongoing investigation. Turkish reports say Khashoggi was brutally murdered and dismembered inside the consulate by members of an assassination squad with ties to Saudi Crown Prince Mohammed bin Salman.

  • Amex posts beat, PayPal shines, Ford makes moves
    Finance
    Yahoo Finance

    Amex posts beat, PayPal shines, Ford makes moves

    American Express beat expectations in its latest earnings. Profit was up 22% last quarter and Amex says it expects full year revenue to rise upwards of 10%. The company also says it just signed a deal to let customers pay their bills through PayPal. Speaking of PayPal, it also posted a big beat in its latest earnings report. A surge in payment volume for Venmo helped boost the bottom line, with overall revenue up 14%. PayPal says it added a record $9.1M accounts in the third quarter.

  • Business
    Bloomberg

    Sears Burns Cash While Betting on Lampert Loans for Survival

    Sears is expected to bleed $220 million in just the first month of its bankruptcy, court filings show, cutting deep into the $300 million loan it secured this week from senior lenders. The crunch could become more acute if Sears doesn’t get an additional $300 million it’s counting on from Chairman Eddie Lampert to keep operating beyond the next 15 days. The retailer is staking its turnaround on getting a $112 million loan from Lampert’s ESL Investments hedge fund by Nov. 3, according to a budget approved by the court, and another $188 million over the following two months.

  • Goldman Sachs Adds Nvidia To 'Conviction Buy' List
    Business
    Yahoo Finance Video

    Goldman Sachs Adds Nvidia To 'Conviction Buy' List

    Goldman Sachs analyst Toshiya Hari reiterated his 'Buy' rating for Nvidia and added the chip-maker to Goldman’s 'Conviction Buy' list.

  • Why Activision Blizzard, United Rentals, and Gap Slumped Today
    Business
    Motley Fool

    Why Activision Blizzard, United Rentals, and Gap Slumped Today

    The stock market had a tough session on Thursday, with the Dow Jones Industrial Average finishing down over 300 points. Investors continued to worry about rising interest rates in the U.S., but they also turned their attention to the global macroeconomic picture, where new concerns about the prospects for growth in areas like Europe and China weighed on sentiment. Company-specific news hurt certain stocks, and Activision Blizzard (NASDAQ: ATVI), United Rentals (NYSE: URI), and Gap (NYSE: GPS) were among the worst performers on the day.

  • Product demand helps Procter & Gamble beat profit, sales estimates
    Business
    Reuters

    Product demand helps Procter & Gamble beat profit, sales estimates

    Organic sales, which exclude revenue from newly acquired units, enjoyed growth of 4 percent, the best in five years. Sales surged 5 percent in P&G's beauty business, driven by its premium skin care brands SK-II and Olay. Shares in the company, which makes Pampers diapers and Tide detergent, jumped 4.8 percent in premarket trading.

  • What’s Pfizer’s Current Valuation?
    Finance
    Market Realist

    What’s Pfizer’s Current Valuation?

    Pfizer's Stock Performance and Estimates in October (Continued from Prior Part) Pfizer’s valuation In this part, we’ll compare Pfizer’s (PFE) valuation with its peers including Merck (MRK), Johnson & Johnson (JNJ), Eli Lilly (LLY), and Bristol-Myers

  • American Electric Power: Analysts’ Recommendations
    Finance
    Market Realist

    American Electric Power: Analysts’ Recommendations

    Analyzing AEP’s Performance before its Q3 2018 Earnings (Continued from Prior Part) Analysts’ recommendations As of October 17, Reuters compiled data from 19 analysts tracking American Electric Power Company (AEP) stock. Five analysts recommended a “

  • The ‘smart money’ says it’s time to buy the Chinese internet giants and the U.S. FAANGs
    News
    MarketWatch

    The ‘smart money’ says it’s time to buy the Chinese internet giants and the U.S. FAANGs

    When the media and investors turn negative on stocks but the “smart money” is bullish, it’s a good time to think about buying. After all, exactly what is the smart money, and how do you know? Lately, several fund managers who pass this test have been pounding the table on Chinese internet names.

  • Provocateur Stormy Daniels Takes an Unexpected Turn in the National Spotlight
    Politics
    Time

    Provocateur Stormy Daniels Takes an Unexpected Turn in the National Spotlight

    To understand what it means to be famous like Stormy Daniels, for the reasons she is famous, spend time with her in a public space. On Oct. 15, a California judge threw out the defamation case she filed against Donald Trump. Over the past year, Daniels, 39, has become the Zelig of White House scandals.

  • Better Buy: GlaxoSmithKline plc vs. Eli Lilly
    Business
    Motley Fool

    Better Buy: GlaxoSmithKline plc vs. Eli Lilly

    People get sick regardless of the economic cycle, so companies that cater to healing them often outperform during downturns, and their stocks are considered "defensive." Healthy and dependable dividends can also contribute to stabilizing portfolio returns in good times and bad. Two successful blue-chip stocks in the healthcare industry are British GlaxoSmithKline plc (NYSE: GSK) and Eli Lilly (NYSE: LLY). Investors like both stocks for their dividends and consistent performance, but the companies are really quite different, with GlaxoSmithKline diversified into vaccines and consumer products, and Eli Lilly focused on pharmaceuticals.

  • Intuitive Surgical (ISRG) Beats on Q3 Earnings & Revenues
    Business
    Zacks

    Intuitive Surgical (ISRG) Beats on Q3 Earnings & Revenues

    Intuitive Surgical, Inc ISRG reported adjusted earnings of $2.83 per share in the third quarter of 2018, which beat the Zacks Consensus Estimate of $2.65. The figure also surpassed the Zacks Consensus Estimate of $918.6 million. In the reported quarter, System revenues increased 4.8% year over year to $274.6 million.

  • IBM Earnings: More Good Than Bad
    Business
    Motley Fool

    IBM Earnings: More Good Than Bad

    After three consecutive quarters of revenue growth, International Business Machines (NYSE: IBM) was unable to keep the ball rolling in the third quarter. Revenue declined by 2% year over year to $18.8 billion, missing the average analyst estimate by more